Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases

Advances in allogeneic hematopoietic cell transplantation for sickle cell disease have improved outcomes, but there is limited analysis of healthcare utilization in this setting. We hypothesized that, compared to late transplantation, early transplantation (at age <10 years) improves outcomes and...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnold, Staci D., Brazauskas, Ruta, He, Naya, Li, Yimei, Aplenc, Richard, Jin, Zhezhen, Hall, Matt, Atsuta, Yoshiko, Dalal, Jignesh, Hahn, Theresa, Khera, Nandita, Bonfim, Carmem, Majhail, Navneet S., Diaz, Miguel Angel, Freytes, Cesar O., Wood, William A., Savani, Bipin N., Kamble, Rammurti T., Parsons, Susan, Ahmed, Ibrahim, Sullivan, Keith, Beattie, Sara, Dandoy, Christopher, Munker, Reinhold, Marino, Susana, Bitan, Menachem, Abdel-Azim, Hisham, Aljurf, Mahmoud, Olsson, Richard F., Joshi, Sarita, Buchbinder, Dave, Eckrich, Michael J., Hashmi, Shahrukh, Lazarus, Hillard, Marks, David I., Steinberg, Amir, Saad, Ayman, Gergis, Usama, Krishnamurti, Lakshmanan, Abraham, Allistair, Rangarajan, Hemalatha G., Walters, Mark, Lipscomb, Joseph, Saber, Wael, Satwani, Prakash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664386/
https://www.ncbi.nlm.nih.gov/pubmed/28818869
http://dx.doi.org/10.3324/haematol.2017.169581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664386/
https://www.ncbi.nlm.nih.gov/pubmed/28818869
http://dx.doi.org/10.3324/haematol.2017.169581

Ejemplares similares